Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$84.53
-3.8%		$81.95
$54.11
▼
$92.59
$33.17B1.423.69 million shs8.22 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-3.83%-6.22%-0.26%+13.05%+8.37%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$84.53
-3.8%		$81.95
$54.11
▼
$92.59
$33.17B1.423.69 million shs8.22 million shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-3.83%-6.22%-0.26%+13.05%+8.37%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.92
Moderate Buy$88.714.94% Upside

Current Analyst Ratings Breakdown

Latest DXCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/4/2026
DexCom, Inc. stock logo
DXCM
DexCom
Argus logo
Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$86.00 ➝ $96.00
8/3/2026
DexCom, Inc. stock logo
DXCM
DexCom
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$82.00 ➝ $90.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy$94.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$88.00 ➝ $95.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$105.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$84.00 ➝ $88.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$80.00 ➝ $90.00
7/31/2026
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$87.00 ➝ $93.00
(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.97B6.42$2.66 per share31.75$7.04 per share12.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5333.4127.441.4720.12%35.94%14.75%10/29/2026 (Estimated)

Latest DXCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable

Recent News About These Companies

Saudi Central Bank Increases Holdings in DexCom, Inc. $DXCM
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-saudi-central-bank-increases-holdings-in-dexcom-inc-dxcm-2026-09-09/
DexCom Stock: Is DXCM Underperforming the Healthcare Sector?
September 8 at 4:16 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/dexcom-stock-dxcm-underperforming-healthcare-123657602.html
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $36.28 Million in DexCom, Inc. $DXCM
September 8 at 5:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-virginia-retirement-systems-et-al-invests-3628-million-in-dexcom-inc-dxcm-2026-09-08/
DexCom, Inc. $DXCM Stake Lessened by Groupe la Francaise
September 8 at 4:24 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-dexcom-inc-dxcm-stake-lessened-by-groupe-la-francaise-2026-09-08/
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
September 7 at 3:27 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-dexcom-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302870963.html
Nykredit A S Purchases New Holdings in DexCom, Inc. $DXCM
September 6 at 4:56 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-nykredit-a-s-purchases-new-holdings-in-dexcom-inc-dxcm-2026-09-06/
DexCom (NASDAQ:DXCM) Upgraded at Wall Street Zen
September 6 at 1:07 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31005638
DexCom (NASDAQ:DXCM) Rating Increased to Buy at Wall Street Zen
September 6 at 1:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-dexcom-nasdaq-dxcm-rating-increased-to-buy-at-wall-street-zen-2026-09-06/
NEOS Investment Management LLC Has $21.68 Million Stake in DexCom, Inc. $DXCM
September 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-neos-investment-management-llc-has-2168-million-stake-in-dexcom-inc-dxcm-2026-09-05/
Brokerages Set DexCom, Inc. (NASDAQ:DXCM) PT at $88.71
September 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31005184
Empowered Funds LLC Buys New Shares in DexCom, Inc. $DXCM
September 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-empowered-funds-llc-buys-new-shares-in-dexcom-inc-dxcm-2026-09-04/
Q2 earnings highs and lows: DexCom (NASDAQ:DXCM) vs the rest of the patient monitoring stocks
September 3, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/q2-earnings-highs-and-lows-dexcom-nasdaqdxcm-vs-the-rest-of-the-patient-monitoring-stocks/ar-AA2bvA5J
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services
September 3, 2026  |  barrons.comhttps://www.barrons.com/articles/revisiting-stock-picks-dexcom-bristol-myers-quanta-services-charts-8ca397e2
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
September 2, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2983700/why-dexcom-dxcm-is-a-top-growth-stock-for-the-long-term?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_growth_score-2983700
3 reasons DXCM has explosive upside potential
September 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/3-reasons-dxcm-has-explosive-upside-potential/ar-AA2bkXdO
Montanova Capital LLC Has $6.87 Million Stock Position in DexCom, Inc. $DXCM
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-montanova-capital-llc-has-687-million-stock-position-in-dexcom-inc-dxcm-2026-09-01/
27,549 Shares in DexCom, Inc. $DXCM Acquired by Quantitative Investment Management LLC
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-27549-shares-in-dexcom-inc-dxcm-acquired-by-quantitative-investment-management-llc-2026-09-01/
Flputnam Investment Management Co. Invests $1.06 Million in DexCom, Inc. $DXCM
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-flputnam-investment-management-co-invests-106-million-in-dexcom-inc-dxcm-2026-09-01/
Here's how much a $1000 investment in DexCom made 10 years ago would be worth today
August 31, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/here-s-how-much-a-1000-investment-in-dexcom-made-10-years-ago-would-be-worth-today/ar-AA2bgPXK
Public Employees Retirement System of Ohio Invests $13.94 Million in DexCom, Inc. $DXCM
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-invests-1394-million-in-dexcom-inc-dxcm-2026-08-31/
DexCom, Inc. (NASDAQ:DXCM) Receives Average Rating of "Moderate Buy" from Brokerages
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-dexcom-inc-nasdaq-dxcm-receives-average-rating-of-moderate-buy-from-brokerages-2026-08-31/

New MarketBeat Followers Over Time

Media Sentiment Over Time

DexCom stock logo

DexCom NASDAQ:DXCM

$84.53 -3.37 (-3.83%)
Closing price 09/8/2026 04:00 PM Eastern
Extended Trading
$84.01 -0.52 (-0.62%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas